[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362442-105":59,"doc-detail-362442-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-lactylation-related-biomarkers-for-diagnosis-prognosis-and-treatment-responsiveness-in-triple-negative-breast-cancer","Identification of lactylation-related biomarkers for diagnosis, prognosis, and treatment responsiveness in triple-negative breast cancer","","Triple-negative breast cancer (TNBC) is an aggressive subtype lacking reliable therapeutic targets and robust prognostic biomarkers. This study explores lactylation, an emerging post-translational modification, by analyzing lactylation-related genes (LRGs) and their clinicopathologic and prognostic roles. Differential expression and WGCNA identify hub LRGs, which drive molecular subtyping, immune infiltration assessment, and diagnostic modeling using multiple machine-learning algorithms. Cox regression supports PGK1 as an independent risk factor and a prognostic marker, with experimental validation linking PGK1 to the lactate-lactylation axis and TNBC malignancy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-lactylation-related-biomarkers-for-diagnosis-prognosis-and-treatment-responsiveness-in-triple-negative-breast-cancer/362442/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-lactylation-related-biomarkers-for-diagnosis-prognosis-and-treatment-responsiveness-in-triple-negative-breast-cancer/362442.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study target in triple-negative breast cancer (TNBC)?","Question",{"text":112,"@type":113},"TNBC is described as highly aggressive and heterogeneous, with limited effective therapeutic targets and insufficient prognostic biomarkers. The study aims to identify lactylation-related biomarkers that support diagnosis, prognosis, and treatment responsiveness.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were lactylation-related genes (LRGs) and biomarkers identified?",{"text":117,"@type":113},"Hub LRGs were identified using differential expression analysis and weighted gene co-expression network analysis (WGCNA). Diagnostic biomarkers were screened by constructing 117 models with nine machine learning algorithms and evaluating them with ROC analysis and nomograms.",{"name":119,"@type":110,"acceptedAnswer":120},"What key biological mechanism links PGK1 to TNBC malignancy?",{"text":121,"@type":113},"PGK1 is validated as an independent risk factor. Mechanistic evidence indicates PGK1 affects lactate metabolism and global lactylation, where PGK1 knockdown lowers intracellular lactate and overall lysine lactylation; lactate supplementation can restore proliferation and proliferation-related defects.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362442,1790520818,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Chao et al. World Journal of Surgical Oncology (2026) 24:77  \n[https://doi.org/10.1186/s12957-026-04201-0](https://doi.org/10.1186/s12957-026-04201-0)  \nWorld Journal of Surgical Oncology  \nRESEARCH Open Access  \nIdentification of lactylation-related biomarkers  for diagnosis, prognosis, and treatment responsiveness in triple-negative breast  \ncancer  \nLemuge Chao1, Yue Xu2, YulanYang1, Xudong Ao1,2* and Junqing Liang1*  \nAbstract  \nBackground Triple-negative breast cancer (TNBC), a highly aggressive subtype of invasive breast cancer, lacks effective therapeutic targets and robust prognostic biomarkers. Lactylation, an emerging post-translational modification, is increasingly recognized for its potential role in tumorigenesis and progression. However, the functional significance of lactylation-related genes (LRGs) inTNBC clinicopathology and prognosis remains poorly defined.  \nMethods We employed a combination of differential expression analysis and weighted gene co-expression network analysis (WGCNA) to identify hub LRGs inTNBC. Consensus clustering was used to stratify TNBC samples into distinct molecular subtypes based on hub LRGs. Immune infiltration and functional differences between the two subtypes were further evaluated using single-sample gene set enrichment analysis (ssGSEA) and Gene Set Variation Analysis (GSVA) . To screen optimal diagnostic biomarkers, we constructed 117 diagnostic models using nine machine learning algorithms and assessed their efficiency through receiver operating characteristic (ROC) analysis and nomograms. Additionally, Cox regression analysis was conducted to evaluate the prognostic potential of hub LRGs inTNBC. Furthermore, we proposed treatment recommendations forTNBC patients based on immunophenotyping and drug sensitivity analysis. Aberrant expression of biomarkers inTNBC tissues was validated using immunohistochemistry. The impact of key biomarkers onTNBC cell proliferation and migration was investigated via CCK-8, transwell, and wound healing assays. Mechanistically, the role of PGK1 in regulating lactate metabolism and global lactylation was assessed by measuring lactate and lactate modification levels, combined with quantitative lactylome proteomics analysis. Results We identified 10 differentially expressed hub LRGs through intersection analysis, which effectively classified TNBC samples into two subtypes exhibiting significant heterogeneity in the tumor immune microenvironment. Among 117 diagnostic models, the optimal model achieved 90% accuracy in the detection ofTNBC. Cox regression analysis confirmed PGK1 as an independent risk factor and potential prognostic marker forTNBC. Patients with  \n*Correspondence:  \nXudong Ao [xudong_ao@immu.edu.cn](xudong_ao@immu.edu.cn)[ ](xudong_ao@immu.edu.cn)Junqing Liang [Liang_junqing@126.com](Liang_junqing@126.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/","cbCaigoxqBudNvyL","https://ap.wps.com/l/cbCaigoxqBudNvyL","pdf",13971361,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## TNBC overview and challenges","[{\"question\":\"What problem does the study target in triple-negative breast cancer (TNBC)?\",\"answer\":\"TNBC is described as highly aggressive and heterogeneous, with limited effective therapeutic targets and insufficient prognostic biomarkers. The study aims to identify lactylation-related biomarkers that support diagnosis, prognosis, and treatment responsiveness.\"},{\"question\":\"How were lactylation-related genes (LRGs) and biomarkers identified?\",\"answer\":\"Hub LRGs were identified using differential expression analysis and weighted gene co-expression network analysis (WGCNA). Diagnostic biomarkers were screened by constructing 117 models with nine machine learning algorithms and evaluating them with ROC analysis and nomograms.\"},{\"question\":\"What key biological mechanism links PGK1 to TNBC malignancy?\",\"answer\":\"PGK1 is validated as an independent risk factor. Mechanistic evidence indicates PGK1 affects lactate metabolism and global lactylation, where PGK1 knockdown lowers intracellular lactate and overall lysine lactylation; lactate supplementation can restore proliferation and proliferation-related defects.\"}]","Identification of lactylation-related biomarkers for diagnosis, prognosis, and treatment responsiveness in triple-negative breast cancer | PDF",1790147775,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78fa59b4db9dff25c08c5670756a48a0.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7835aedd41d79b145256874d74887599.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b537726e4a8f19d2e32bf8b46fb25cc3.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2cc30801d7c01177666858c2e258f90.webp",980,1306]